Equitable Holdings
EQH
$48.99
-0.02%
Equitable Holdings is a financial services company providing retirement, asset management, and wealth management solutions through its Retirement, Asset Management (AllianceBernstein), and Wealth Management segments. As a diversified insurance and asset manager, it distinguishes itself with a leading position in variable annuities and a strong brand in retirement planning. The current investor narrative centers on the company's earnings recovery after a volatile 2025, with a sharp rebound in Q1 2026 profitability and a significant share buyback program signaling management confidence.…
EQH
Equitable Holdings
$48.99
Related headlines
Investment Opinion: Should I buy EQH Today?
Rating: Buy. The thesis is that EQH's sharp earnings recovery, combined with a low forward P/E of 5.5x and strong free cash flow, offers a compelling risk/reward opportunity. The analyst consensus is Strong Buy with an average target of $60.82, implying 24.2% upside.
Supporting evidence: (1) Forward P/E of 5.49x is near historical lows and well below the industry average. (2) Revenue grew 8.35% YoY to $4.23B in Q1 2026, accelerating from prior quarters. (3) Net margin improved to 14.68% from 6.56% in Q4 2025, showing strong operating leverage. (4) Free cash flow turned positive at $490M in Q1 2026, supporting buybacks and dividends. (5) The PEG ratio of 0.04 suggests the stock is undervalued relative to its growth rate.
Risks & Conditions: The biggest risks are earnings sustainability, balance sheet leverage, and macro sensitivity. This Buy rating would be downgraded to Hold if Q2 2026 earnings show a sequential decline in net income or if the forward P/E expands above 8x without corresponding growth. It would be upgraded to Strong Buy if the company raises guidance or announces a larger buyback. Overall, EQH appears undervalued relative to its earnings power and analyst targets, offering a favorable entry point for value-oriented investors.
Sign up to view all
EQH 12-Month Price Forecast
The AI assessment is bullish with medium confidence. The combination of a low forward P/E, strong earnings recovery, and positive analyst sentiment supports a favorable outlook. However, the medium confidence reflects the recent earnings volatility and balance sheet risks. The key factor to watch is the sustainability of Q1 2026's profitability. If the company delivers another quarter of strong earnings, the stance would upgrade to high confidence. Conversely, any earnings miss would trigger a reassessment.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Equitable Holdings's 12-month outlook, with a consensus price target around $60.82 and implied upside of +24.1% versus the current price.
Average Target
$60.82
0 analysts
Implied Upside
+24.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$50 - $68
Analyst target range
The stock is covered by 11 analysts, with a consensus recommendation of 'Strong Buy' (mean 1.33 on a 1-5 scale). The average target price is $60.82, implying approximately 24.2% upside from the current price of $48.99. The distribution leans heavily bullish, with no hold or sell ratings in the recent data, indicating strong conviction among analysts. The target price range spans from $50.00 (low) to $68.00 (high). The high target of $68.00 assumes continued earnings momentum and potential multiple expansion, while the low target of $50.00 still implies modest upside and reflects a more conservative view on recovery sustainability. Recent ratings from firms like Keefe Bruyette & Woods, Evercore ISI, and Jefferies have all reaffirmed positive stances (Outperform/Buy), with no downgrades in the last three months, reinforcing the bullish consensus.
Drowning in data?
Find the real signal!
Bulls vs Bears: EQH Investment Factors
Equitable Holdings presents a compelling recovery story with a sharp earnings turnaround, strong free cash flow, and a low forward P/E of 5.5x, supported by a unanimous Strong Buy analyst consensus. However, the stock carries significant risks including a leveraged balance sheet, recent earnings volatility, and persistent underperformance versus the market. The bull case currently has stronger evidence given the magnitude of the earnings recovery and attractive valuation, but the key tension is whether the Q1 2026 profitability is sustainable or a one-time event. If earnings continue to improve, the stock could re-rate higher; if not, the low forward P/E may prove justified.
Bullish
- Strong Earnings Recovery: Net income swung from a loss of $1.31B in Q3 2025 to a profit of $621M in Q1 2026, a dramatic turnaround. This recovery is supported by revenue growth of 8.35% YoY to $4.23B, demonstrating top-line resilience.
- Low Forward P/E of 5.5x: The forward P/E of 5.49x is near the low end of its historical range (1.45x-81.39x) and suggests the market is pricing in conservative expectations. If earnings are sustainable, this implies significant upside potential.
- Analyst Consensus Strong Buy: All 11 analysts rate the stock a Strong Buy (mean 1.33/5), with an average target of $60.82, implying 24.2% upside. No hold or sell ratings exist, reflecting high conviction in the recovery story.
- Robust Free Cash Flow Generation: Free cash flow improved to $490M in Q1 2026 from negative $64M in Q4 2025, with TTM FCF of $807M. This provides financial flexibility for dividends and the announced share buyback program.
Bearish
- Negative Trailing P/E Due to Losses: The trailing P/E is -9.87x because of prior losses, highlighting earnings volatility. The company reported losses in Q2 and Q3 2025, raising questions about the sustainability of the recovery.
- High Debt-to-Equity Ratio: Debt-to-equity is -88.68 due to negative equity, indicating a leveraged balance sheet. While common in insurance, this amplifies risk if earnings falter or asset values decline.
- Underperformance vs. S&P 500: Over the past year, EQH returned -6.88% versus the S&P 500's +18.35%, a relative underperformance of 25.23%. This suggests persistent skepticism from the broader market.
- Sensitivity to Interest Rates: With a beta of 1.094, the stock is more volatile than the market. The Retirement segment's spread lending is sensitive to interest rate changes, and a falling rate environment could compress margins.
EQH Technical Analysis
The stock is in a recovery uptrend after a deep drawdown, with a 1-year price change of -6.88% reflecting the prior decline, but the current price of $48.99 sits at 88.7% of its 52-week range ($35.20-$55.24), indicating a strong rebound from the lows. This positioning near the upper end of the range suggests positive momentum but also potential resistance as it approaches the 52-week high. Short-term momentum is robust, with 1-month and 3-month price changes of +7.67% and +17.40%, respectively, significantly outperforming the S&P 500's +0.31% and +4.67% over the same periods. This acceleration in momentum relative to the longer-term trend signals a potential trend reversal from the prior downtrend, supported by a relative strength of +12.73% over 3 months versus the market. The 52-week high of $55.24 acts as key resistance; a breakout above this level would confirm a new uptrend, while the 52-week low of $35.20 provides support. With a beta of 1.094, the stock is slightly more volatile than the market, meaning it tends to amplify market moves, which is important for risk management.
Beta
1.09
1.09x market volatility
Max Drawdown
-37.0%
Largest decline past year
52-Week Range
$35-$55
Price range past year
Annual Return
-6.9%
Cumulative gain past year
| Period | EQH Return | S&P 500 |
|---|---|---|
| 1m | +7.7% | -0.5% |
| 3m | +17.4% | +4.9% |
| 6m | +4.8% | +9.7% |
| 1y | -6.9% | +18.4% |
| ytd | +2.1% | +9.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EQH Fundamental Analysis
Revenue grew 8.35% year-over-year to $4.23 billion in Q1 2026, accelerating from the prior quarter's $3.28 billion and reversing a trend of volatile revenue that included a low of $1.45 billion in Q3 2025. The Retirement segment, which generates the majority of revenue, benefits from higher fee income and spread lending, while the Asset Management segment (AllianceBernstein) adds diversification. This growth trajectory supports the investment case by demonstrating top-line resilience and recovery. Net income swung sharply to $621 million in Q1 2026 from a loss of $1.31 billion in Q3 2025, reflecting a dramatic profitability turnaround. Gross margin improved to 90.69% from 88.07% in Q4 2025, while net margin rose to 14.68% from 6.56%, indicating strong operating leverage and cost control. The company is now solidly profitable after a period of losses, which is critical for investor confidence. Free cash flow was $490 million in Q1 2026, up from negative $64 million in Q4 2025, and the company generated $807 million in trailing twelve-month free cash flow. The debt-to-equity ratio is -88.68 (negative equity due to accounting), but the current ratio of 0.57 suggests adequate liquidity. ROE stands at 18.65%, indicating strong return on shareholder equity, though the negative equity base requires careful interpretation.
Quarterly Revenue
$4.2B
2026-03
Revenue YoY Growth
+8.3%
YoY Comparison
Gross Margin
90.7%
Latest Quarter
Free Cash Flow
$807000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EQH Overvalued?
Since net income is positive ($621 million), the primary valuation metric is the P/E ratio. The trailing P/E is -9.87 (negative due to prior losses), but the forward P/E is 5.49x, reflecting the sharp earnings recovery expected. The gap between trailing and forward P/E implies the market anticipates significantly higher earnings, which is consistent with the recent profitability turnaround. Compared to the industry average P/E (not provided), the forward P/E of 5.49x appears low, suggesting a potential value opportunity if earnings are sustainable. The P/S ratio of 1.22x is also modest relative to historical levels. Historically, the stock's trailing P/E has ranged from 1.45x (Q2 2022) to 81.39x (Q1 2025), with the current forward P/E of 5.49x near the lower end of that range. This suggests the market is pricing in conservative expectations, potentially offering a margin of safety if the company continues to deliver strong earnings.
PE
-9.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 1x~39x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-85.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The company's debt-to-equity ratio of -88.68 reflects negative equity, a common but risky structure in insurance. While the current ratio of 0.57 indicates adequate liquidity, the balance sheet leverage amplifies downside risk. Earnings have been highly volatile, with net income swinging from a loss of $1.31B in Q3 2025 to a profit of $621M in Q1 2026, raising concerns about sustainability. The trailing P/E of -9.87x underscores the impact of prior losses, and any reversal in the recovery could lead to sharp valuation compression.
Market & Competitive Risks: The stock's beta of 1.094 makes it more sensitive to market downturns, and its 1-year relative underperformance of -25.23% versus the S&P 500 indicates persistent skepticism. Valuation risk is present despite the low forward P/E, as the market may be correctly pricing in uncertainty. The insurance and asset management sectors face regulatory headwinds and competitive pressure on fees, particularly at AllianceBernstein. A rising rate environment could benefit spread lending, but falling rates would compress margins.
Worst-Case Scenario: If the earnings recovery proves temporary—due to market volatility, reserve charges, or operational setbacks—the stock could retest its 52-week low of $35.20, representing a 28.2% decline from the current price of $48.99. In a severe downturn, the stock could fall to the analyst low target of $50.00, but a break below the 52-week low would imply a loss of over 28%. The historical max drawdown of -37.01% suggests that in a worst-case scenario, an investor could lose approximately 37% from current levels.
FAQ
The key risks are: (1) Earnings sustainability – the company reported losses in Q2 and Q3 2025, and any reversal could lead to sharp declines. (2) Balance sheet leverage – debt-to-equity of -88.68 reflects negative equity, amplifying downside risk. (3) Market sensitivity – with a beta of 1.094, the stock is more volatile than the market and underperformed the S&P 500 by 25.23% over the past year. (4) Interest rate risk – the Retirement segment's spread lending is sensitive to rate changes; falling rates could compress margins. The most severe risk is a return to losses, which could drive the stock to its 52-week low of $35.20.
The 12-month forecast is positive, with a base case target of $55-$61 (50% probability) based on sustained earnings recovery. The bull case (30% probability) targets $60-$68, driven by continued growth and multiple expansion. The bear case (20% probability) sees the stock falling to $35-$50 if earnings disappoint. The analyst consensus is Strong Buy with an average target of $60.82. The most likely scenario is the base case, assuming net income remains above $600M per quarter. Key catalysts include the next earnings report and share buyback announcements.
EQH appears undervalued based on its forward P/E of 5.49x, which is near the low end of its historical range of 1.45x to 81.39x. The PEG ratio of 0.04 suggests the stock is cheap relative to its earnings growth rate. Compared to the industry average (not provided), the forward P/E is low, implying the market is pricing in conservative expectations. The P/S ratio of 1.22x is also modest. However, the trailing P/E is negative due to prior losses, so the valuation depends on the sustainability of the recovery. If earnings continue to grow, the stock is undervalued; if not, the low multiple may be justified.
EQH appears to be a good buy for value-oriented investors with a medium-term horizon. The stock trades at a forward P/E of 5.49x, near historical lows, and analysts see 24.2% upside to the average target of $60.82. The company has demonstrated a strong earnings recovery, with net income swinging to $621M in Q1 2026 from a loss of $1.31B in Q3 2025. However, the stock carries risks including a leveraged balance sheet and earnings volatility. It is best suited for investors who can tolerate potential drawdowns of up to 28% (to the 52-week low) in exchange for the upside potential.
EQH is better suited for medium-to-long-term investment given its value profile and recovery story. The stock has a beta of 1.094, indicating higher volatility, which may not suit short-term traders seeking stability. The dividend yield of 2.64% provides some income, but the primary appeal is capital appreciation from a low valuation. A minimum holding period of 12-18 months is recommended to allow the earnings recovery to materialize and the market to re-rate the stock. Short-term trading is riskier due to earnings volatility and macro sensitivity.
